重楼生化汤对剖宫产术后子宫内膜MMP-9及其抑制物TIMP-1表达及血白细胞、C-反应蛋白的影响

中国临床药理学与治疗学 ›› 2014, Vol. 19 ›› Issue (5): 542-547.

重楼生化汤对剖宫产术后子宫内膜MMP-9及其抑制物TIMP-1表达及血白细胞、C-反应蛋白的影响

江延姣¹, 叶慧君¹, 刘佳俐¹, 赵再秋², 孙凯²

¹浙江中医药大学附属第二医院妇产科;
²病理科,杭州 310005,浙江

收稿日期:2014-02-22 修回日期:2014-04-22 出版日期:2014-05-26 发布日期:2014-06-05
通讯作者: 叶慧君,女,学士,主任医师,研究方向:妇科肿瘤及内分泌。Tel: 0571-85288322 E-mail: yehuihui1213@126.com
作者简介:江延姣,女,硕士,主治医师/讲师,研究方向:围产医学及妇科内分泌。Tel: 13185719869 E-mail: jiangyanjiao0518@aliyun.com
基金资助:
浙江省中医药管理局科研项目(2012ZB068);浙江中医药大学校级科研项目(2011ZY15)

Effect of Chonglou Shenghua Tang on the expression of MMP-9 and TIMP-1 in endometrium and blood leukocyte and C-reactive protein level after caesarian section

JIANG Yan-jiao¹, YE Hui-jun¹, LIU Jia-li¹, ZHAO Zai-qiu², SUN Kai²

¹Department of Gynaecology and Obstetrics, the Second Affiliated Hospital of Zhejiang Chinese Medical University;
²Department of Pathology, Hangzhou 310005, Zhejiang, China

Received:2014-02-22 Revised:2014-04-22 Online:2014-05-26 Published:2014-06-05

摘要/Abstract

摘要： 目的:观察重楼生化汤对剖宫产术后子宫内膜基质金属蛋白酶-9(MMP-9)及其基质金属蛋白酶抑制物-1(TIMP-1)表达的影响,以及血白细胞计数、中性粒细胞百分比、血清C-反应蛋白(CRP)的变化,探讨其预防剖宫产术后恶露不绝的机理。方法:选择符合纳入标准及排除标准剖宫产术后产妇60例,随机分成三组,其中实验组(重楼生化汤组)20例,于术后 6 h 起予重楼生化汤 100 mL,2次/d,连服 14 d;对照1组(经典生化汤组)20例,术后6 h起予经典生化汤 100 mL,2次/d,连服 14 d;安慰剂组20例,术后6 h起予安慰剂 100 mL,2次/d,连服 14 d。术后第16天应用免疫组织化学法检测各组子宫内膜组织MMP-9及其抑制物TIMP-1的表达,术后第5天、第16天检测血液白细胞计数、中性粒细胞百分比、CRP的变化。结果:重楼生化汤组、经典生化汤组、安慰剂组子宫内膜组织中MMP-9表达依次上升,各组间比较有统计学差异(P均＜0.05)。三组TIMP-1表达从高到低依次为:重楼生化汤组、经典生化汤组、安慰剂组。重楼生化汤组显著高于经典生化汤组和安慰剂组(P均＜0.05),经典生化汤组与安慰剂组比较无统计学差异(P＞0.05)。重楼生化汤组、经典生化汤组、安慰剂组MMP-9/TIMP-1比值依次升高,各组间比较有统计学差异(P均＜0.05)。重楼生化汤组、经典生化汤组、安慰剂组术后第5天血白细胞计数、中性粒细胞百分比、CRP,术后第16天血中性粒细胞百分比、CRP依次升高,各组间比较有统计学差异(P均＜0.05),术后第16天血白细胞计数各组间比较无统计学差异(P＞0.05)。结论:重楼生化汤降低剖宫产术后产妇子宫内膜组织MMP-9的表达,升高TIMP-1的表达,使MMP-9/TIMP-1降低,降低血液中炎性指标与其预防剖宫产术后恶露不绝有关。

关键词: 重楼生化汤, 基质金属蛋白酶, 白细胞, C-反应蛋白, 剖宫产, 恶露不绝

Abstract: AIM: To detect the expression of matrix metalloproteinases-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in endometrium after caesarian section, and the change of blood leukocyte count, neutrophil percentage, serum C-reactive protein (CRP) level, and to explore the mechanism of Chonglou Shenghua Tang for preventing lochiorrhagia after caesarian section (CS).METHODS: The prospective study was designed as randomized and single blind research from Jan 2011 to Jan 2013. 60 women underwent caesarian section (CS) indicated by obstetric factors were enrolled from the 2ED clinical medical college of Zhejiang Chinese Medical University and assigned into three groups: group of Chonglou Shenghua Tang: 20 cases were administered by Chonglou Shenghua Tang 100 mL, per 12 h 14 d after CS; group of Classical Shenghua Tang: 20 cases were administered by Classical Shenghua Tang 100 mL, per 12 h 14 d after CS and group of placebo: 20 cases were administered by placebo 100 mL, per 12 h 14 d after CS. The expressions of MMP-9 and TIMP-1 in endometrium were determined using immunohistochemistry at 16th days after CS, and blood leukocyte and CRP were detected at 5th days and 16th days after CS.RESULTS: The levels of MMP-9 expression decreased gradually in Chonglou Shenghua Tang group, Classical Shenghua Tang group and placebo group at 16th days after CS, respectively, with statistical significance (P＜0.05). The levels of TIMP-9 expression and the ratio of MMP-9/TIMP-1 increased gradually in Chonglou Shenghua Tang group, Classical Shenghua Tang group and placebo group at 16th days after CS,respectively, with statistical significance (P＜0.05). Blood leukocyte count, neutrophil percentage and CRP increased gradually in Chonglou Shenghua Tang group, Classical Shenghua Tang group and placebo group at 5th days and 16th days after CS, respectively, with statistical significance (P＜0.05).CONCLUSION: These results suggest that reduced expressions of MMP-9, and increased TIMP-1,and reduced the ratio MMP-9/TIMP-1 in endometrium and reduced inflammatory indexes in the blood may play important roles in Chonglou Shenghua Tang preventing lochia after cesarean section.

Key words: Chonglou Shenghua Tang, matrix metalliproteinases, blood leukocyte, C-reactive protein, caesarian section, lochiorrhagia

中图分类号:

R714.4

江延姣, 叶慧君, 刘佳俐, 赵再秋, 孙凯. 重楼生化汤对剖宫产术后子宫内膜MMP-9及其抑制物TIMP-1表达及血白细胞、C-反应蛋白的影响[J]. 中国临床药理学与治疗学, 2014, 19(5): 542-547.

JIANG Yan-jiao, YE Hui-jun, LIU Jia-li, ZHAO Zai-qiu, SUN Kai. Effect of Chonglou Shenghua Tang on the expression of MMP-9 and TIMP-1 in endometrium and blood leukocyte and C-reactive protein level after caesarian section[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(5): 542-547.

参考文献

[1] Evans J, Salamonsen LA. Inflammation, leukocytes and menstruation[J]. Rev Endocr Metab Disord, 2012, 13(4): 277-288.
[2] Wathes DC, Cheng Z, Fenwick MA, et al. Influence of energy balance on the somatotrophic axis and matrix metalloproteinase expression in the endometrium of the postpartum dairy cow[J]. Reproduction, 2011, 141(2): 269-281.
[3] Lirussi F, O'Brien M, Wendremaire M, et al. SAR150640, a selective b3-adrenoceptor agonist prevents human myometrial remodelling and activation of matrix metalloproteinase in an in vitro model of chorioamnionitis[J]. Br J Pharmacol, 2010, 159(6): 1354-1366.
[4] Saravanan C, Singh SK. Status of research on MMPs in India[J]. Expert Opin Ther Targets, 2011, 15(6): 715-728.
[5] Gaide Chevronnay HP, Selvais C, Emonard H, et al. Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration[J]. Biochim Biophys Acta, 2012, 1824(1): 146-156.
[6] Dong JC, Dong H, Campana A, et al. Matrix metalloproteinases and their speciflc tissue inhibitors in menstruation[J]. Reproduction, 2002, 123(5): 621-631.
[7] Lockwood CJ. Mechanisms of normal and abnormal endometrial bleeding[J]. Menopause, 2011, 18(4): 408-411.
[8] Zhang X, Qi C, Lin J. Enhanced expressions of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factors (VEGF) and increased microvascular density in the endometrial hyperplasia of women with anovulatory dysfunctional uterine bleeding[J]. Fertil Steril, 2010, 93(7): 2362-2367.
[9] 周赞华, 黄丽丽. 米非司酮药物流产后子宫异常出血与内膜MMP-9、TIMP-1的关系研究[J]. 中国计划生育学杂志, 2009, 160(2): 87-90.
[10] Manase K, Endo T, Chida M, et al. Coordinated elevation of membrane type 1-matrix metalloproteinase and matrix metalloproteinase-2 expression in rat uterus during postpartum involution[J]. Reprod Biol Endocrinol, 2006, 4:32.
[11] 曾晶, 尤昭玲, 查亚萍, 等. 妇科止血消痛颗粒对产后子宫复旧不全大鼠模型子宫MMP-9、TIMP-l mRNA表达的影响[J]. 中国中医药信息杂志, 2011, 17(6): 31-33.
[12] 杨晓艳, 黄丽红. 宫血宁胶囊预防异常产褥的临床疗效观察[D]. 湖北中医学院, 2009硕士学位论文.
[13] 管璐晗, 王伯初. 中药重楼的化学成分及其活性研究[D]. 重庆大学,2007硕士学位论文.
[14] 林建华, 林其德, 刘兴会, 等. 益母草注射液预防剖宫产产后出血的多中心临床研究[J]. 中华妇产科杂志, 2009, 44(3): 175-180.

[1]	李阳, 潘维忠, 张晓录, 于翠翠. 回收式自体血回输对行剖宫产术患者免疫功能及炎症反应的影响[J]. 中国临床药理学与治疗学, 2023, 28(5): 514-524.
[2]	冯艳, 李高炜, 金琪琪, 蔡伟茶, 林学正, 李军. 艾司氯胺酮和布托啡诺对剖宫产产妇吗啡所致瘙痒影响的随机对照临床研究[J]. 中国临床药理学与治疗学, 2022, 27(12): 1425-1430.
[3]	李弘，刘叶倩，龚姗，刘林，曾勇，蔡晓，王宇红，任卫琼. 复方七芍降压片对自发性高血压大鼠肠系膜动脉中Ⅰ、Ⅲ型胶原蛋白表达及血压的影响[J]. 中国临床药理学与治疗学, 2019, 24(12): 1364-1370.
[4]	张倩, 付红, 陈瑾瑾, 朱余兵. IL-33/ST2在急性冠脉综合征中的研究进展[J]. 中国临床药理学与治疗学, 2018, 23(9): 1075-1080.
[5]	周勇，应莉，徐佳佳，丁世雄，胡爱荣，高国生. 可溶性人类白细胞抗原G对丙型肝炎初治患者标准化治疗疗效的影响[J]. 中国临床药理学与治疗学, 2018, 23(7): 809-813.
[6]	戴备军，翁剑枫，胡志斌. 基质金属蛋白酶-9和内皮祖细胞在心脏移植术患者中表达的相关性及临床意义[J]. 中国临床药理学与治疗学, 2018, 23(3): 296-300.
[7]	何合胜，靳小可，徐又海，杨玉琼，刘善浩，齐晶. 调节性B细胞在自身免疫性溶血性贫血患者外周血中的表达及临床意义[J]. 中国临床药理学与治疗学, 2018, 23(3): 329-332.
[8]	陈祥艳，陈聪，孙云，张虹，高楚楚，陈舒. 益肾抗瘤方联合IL-2腹腔灌注治疗卵巢癌相关腹水的疗效观察[J]. 中国临床药理学与治疗学, 2018, 23(12): 1408-1414.
[9]	张喜平，张翔，杨红健，邹德宏，乔恩奇，王准，何向明，俞星飞，章颖，唐镔镔. 多种复方中药注射液治疗小鼠化疗相关白细胞减少症[J]. 中国临床药理学与治疗学, 2018, 23(10): 1116-1125.
[10]	陈娟燕，宋水江，徐冬娟，徐琼，李鸿飞. 法舒地尔联合瑞舒伐他汀治疗血管性痴呆对认知功能、C-反应蛋白及氧化应激的影响[J]. 中国临床药理学与治疗学, 2018, 23(10): 1153-1158.
[11]	罗勇，李崎，华特波. 新辅助化疗联合乳腺癌改良根治术对乳腺癌患者免疫功能、基质金属蛋白酶及血管内皮生长因子的影响[J]. 中国临床药理学与治疗学, 2018, 23(1): 104-109.
[12]	沈忱，李运曼，夏念，徐丹，韩丹，陈仕杰. Treg细胞抑制基质金属蛋白酶-9对类风湿性关节炎伴急性脑缺血损伤的研究进展[J]. 中国临床药理学与治疗学, 2017, 22(7): 831-840.
[13]	张新民，陈鹏，叶盛，夏武杰，李岳春. 蛋白酶体抑制剂减少病毒性心肌炎小鼠炎症因子IL-6和TNF-α的表达[J]. 中国临床药理学与治疗学, 2017, 22(4): 406-411.
[14]	喻琴云，詹晓峰，黄彦. 刺芒柄花素对去势骨质疏松大鼠P38MAPK/MMP-9信号通路的影响[J]. 中国临床药理学与治疗学, 2017, 22(12): 1371-1376.
[15]	钟海潮，范芳华. IL-32在重症肺炎患者血浆中表达的临床意义及其机制探讨[J]. 中国临床药理学与治疗学, 2016, 21(9): 1024-1027.